Literature DB >> 15687882

Helicobacter infection, chronic inflammation, and the development of malignancy.

Sheila E Crowe1.   

Abstract

PURPOSE OF REVIEW: Chronic infection with Helicobacter pylori affects approximately half the world and results in malignancy in a small subset of this population. Although the frequency of infection in developed nations is falling with a resultant decline in H. pylori-associated peptic ulcer disease, gastric cancer remains the second major cause of cancer death worldwide, with H. pylori infection being a major attributable factor in the development of gastric cancer. This review provides an update on the pathogenesis of Helicobacter infection, the malignancies associated with infection, and how infection and chronic inflammation may lead to the development of gastric malignancy, emphasizing recent developments in the field, particularly those published in leading journals. RECENT
FINDINGS: Recent studies have broadened our understanding of the pathogenesis of chronic inflammation associated with Helicobacter infection, and how chronic inflammation contributes to carcinogenesis. There is also continuing evidence from eradication studies in humans and animal models to support the association of Helicobacter infection with gastric cancer. Although there are some differences in the various human trials, recent studies support the notion that early eradication of infection may prevent the development of malignancy, but once certain events have taken place, the process leading to cancer may not be reversible. Continued research into bacterial and host factors that are associated with an increased risk of the development of gastric cancer have also enhanced our understanding of this field.
SUMMARY: The emerging literature has important implications for the understanding of the basic pathophysiology leading to malignancy in chronic H. pylori infection throughout the world. Treatment of infection may be beneficial in preventing the development of cancer in certain settings, and the role of antioxidants and other approaches is promising but requires further study. Findings from the investigation of host and bacterial factors that may predispose to the development of more severe disease manifestations including gastric cancer are also important developments in this area.

Entities:  

Mesh:

Year:  2005        PMID: 15687882

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  44 in total

1.  Dual regulation by apurinic/apyrimidinic endonuclease-1 inhibits gastric epithelial cell apoptosis during Helicobacter pylori infection.

Authors:  Ranajoy Chattopadhyay; Asima Bhattacharyya; Sheila E Crowe
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  H pylori receptor MHC class II contributes to the dynamic gastric epithelial apoptotic response.

Authors:  David A Bland; Giovanni Suarez; Ellen J Beswick; Johanna C Sierra; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  Tumor necrosis factor (TNF)-alpha-induced IL-8 expression in gastric epithelial cells: role of reactive oxygen species and AP endonuclease-1/redox factor (Ref)-1.

Authors:  Ann M O'Hara; Asima Bhattacharyya; Jie Bai; Randy C Mifflin; Peter B Ernst; Sankar Mitra; Sheila E Crowe
Journal:  Cytokine       Date:  2009-04-18       Impact factor: 3.861

Review 4.  Theories of carcinogenesis: an emerging perspective.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

5.  Outcomes in Patients with Helicobacter pylori Undergoing Laparoscopic Sleeve Gastrectomy.

Authors:  Andrew R Brownlee; Erica Bromberg; Mitchell S Roslin
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

Review 6.  Eradication of H pylori for the prevention of gastric cancer.

Authors:  Karolin Trautmann; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

7.  IL-11 is a parietal cell cytokine that induces atrophic gastritis.

Authors:  Meegan Howlett; Heather V Chalinor; Jon N Buzzelli; Nhung Nguyen; Ian R van Driel; Katrina M Bell; James G Fox; Eva Dimitriadis; Trevelyan R Menheniott; Andrew S Giraud; Louise M Judd
Journal:  Gut       Date:  2011-12-16       Impact factor: 23.059

Review 8.  Field defects in progression to gastrointestinal tract cancers.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Katerina Dvorak; Harinder Garewal
Journal:  Cancer Lett       Date:  2007-12-31       Impact factor: 8.679

9.  Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori.

Authors:  Lee Yeong Yeh; Mahendra Raj; Syed Hassan; Syed Abdul Aziz; Nor Hayati Othman; Samarendra Singh Mutum; Ventakesh R Naik
Journal:  Indian J Gastroenterol       Date:  2009-08-21

10.  Do Langerhans cells play a role in vulvar epithelium resistance to squamous cell carcinoma?

Authors:  Helena Rotsztejn; Ewa Trznadel-Budźko; Dorota Jesionek-Kupnicka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-20       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.